Johnson & Johnson
NYSE: JNJ
$155.86
+$0.69 (+0.4%)
Real Time Data Delayed 15 Min.
JNJ Articles
24/7 Wall St. has chosen a list of companies that will operate fine in times of market turmoil and probably will operate well from financial standpoint even if economic turmoil were to arise.
Published:
Last Updated:
Chevron, Exxon, 3M, and Johnson & Johnson led all 30 DJIA stocks on a second-consecutive unanimous tumble.
Published:
Last Updated:
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
Published:
Last Updated:
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
Boeing, 3M, Johnson & Johnson, and United Technologies pushed the DJIA to a triple-digit gain Thursday.
Published:
Last Updated:
Travelers and General Electric played big roles in helping the Dow finish basically flat Monday. Johnson & Johnson and Procter & Gamble lagged after tepid quarterly results.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of GE, Intel, Verizon and other Dow Jones Industrial Average companies due to report their quarterly results this week.
Published:
Last Updated:
Boeing, General Electric, Johnson & Johnson, and United Technologies were Tuesday's pacesetters among the Dow 30 stocks.
Published:
Last Updated:
Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
Published:
Last Updated:
Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst price target and an expected 2018 total return on each.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Published:
Last Updated:
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
Published:
Last Updated:
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
Published:
Last Updated:
These are four quality companies that should continue to do well in 2018. Investors to want to buy the shares and put them in their accounts for a long time.
Published: